ProBioGen Announces Further Development Milestone for Use of Its GlymaxX Cancer Cell-Killing Enhancement Antibody Technology with Merus N.V. Read more
SOTIO Starts Phase I/II Trial of DCVAC in Combination with ONCOS-102: The Targovax Adenovirus Based Immunotherapy Read more
Lunaphore and Vitro Sign Collaboration Agreement to Develop ISH Protocols for RNA/DNA Targets Read more
BERG Announces FDA Orphan-Drug Designation of BPM 31510 for the Treatment of Patients with Epidermolysis Bullosa Read more
Amgen Enters Groundbreaking Collaboration To Improve Symptom Management During Cancer Treatment Read more